Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CNL Healthcare Properties (CHTH) Gross Profit (2017 - 2025)

Historic Gross Profit for CNL Healthcare Properties (CHTH) over the last 9 years, with Q3 2025 value amounting to $94.8 million.

  • CNL Healthcare Properties' Gross Profit rose 704.59% to $94.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $367.8 million, marking a year-over-year increase of 727.47%. This contributed to the annual value of $349.2 million for FY2024, which is 711.75% up from last year.
  • According to the latest figures from Q3 2025, CNL Healthcare Properties' Gross Profit is $94.8 million, which was up 704.59% from $92.9 million recorded in Q2 2025.
  • Over the past 5 years, CNL Healthcare Properties' Gross Profit peaked at $94.8 million during Q3 2025, and registered a low of $67.6 million during Q1 2021.
  • Over the past 5 years, CNL Healthcare Properties' median Gross Profit value was $81.3 million (recorded in 2023), while the average stood at $81.1 million.
  • Per our database at Business Quant, CNL Healthcare Properties' Gross Profit crashed by 1236.94% in 2021 and then skyrocketed by 1155.39% in 2022.
  • CNL Healthcare Properties' Gross Profit (Quarter) stood at $72.2 million in 2021, then rose by 7.76% to $77.9 million in 2022, then grew by 6.0% to $82.5 million in 2023, then grew by 7.74% to $88.9 million in 2024, then grew by 6.57% to $94.8 million in 2025.
  • Its Gross Profit stands at $94.8 million for Q3 2025, versus $92.9 million for Q2 2025 and $91.3 million for Q1 2025.